Phreesia, Inc. (NYSE:PHR – Get Free Report) COO Evan Roberts sold 16,005 shares of the stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $30.00, for a total transaction of $480,150.00. Following the sale, the chief operating officer now directly owns 748,302 shares of the company’s stock, valued at $22,449,060. The trade was a 2.09 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
Evan Roberts also recently made the following trade(s):
- On Monday, January 27th, Evan Roberts sold 10,716 shares of Phreesia stock. The stock was sold at an average price of $27.48, for a total transaction of $294,475.68.
- On Tuesday, January 21st, Evan Roberts sold 12,749 shares of Phreesia stock. The stock was sold at an average price of $27.31, for a total transaction of $348,175.19.
- On Wednesday, January 15th, Evan Roberts sold 1,785 shares of Phreesia stock. The stock was sold at an average price of $26.98, for a total transaction of $48,159.30.
- On Wednesday, January 8th, Evan Roberts sold 2,681 shares of Phreesia stock. The stock was sold at an average price of $27.95, for a total transaction of $74,933.95.
- On Monday, January 6th, Evan Roberts sold 2,873 shares of Phreesia stock. The stock was sold at an average price of $26.61, for a total transaction of $76,450.53.
Phreesia Stock Performance
Shares of NYSE PHR opened at $29.99 on Wednesday. The firm’s 50-day moving average price is $26.93 and its 200-day moving average price is $23.68. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04. The company has a market cap of $1.74 billion, a PE ratio of -20.40 and a beta of 0.96. Phreesia, Inc. has a 52-week low of $17.07 and a 52-week high of $30.53.
Analyst Ratings Changes
Several research analysts have commented on PHR shares. Citigroup upped their price objective on shares of Phreesia from $31.00 to $35.00 and gave the stock a “buy” rating in a report on Friday, January 10th. Robert W. Baird decreased their price target on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a research note on Wednesday, December 11th. JMP Securities reiterated a “market outperform” rating and issued a $30.00 price target on shares of Phreesia in a research note on Tuesday, December 10th. Truist Financial increased their price target on shares of Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a research note on Wednesday, December 11th. Finally, KeyCorp increased their price target on shares of Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 8th. Thirteen analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $31.15.
Read Our Latest Stock Report on PHR
Institutional Trading of Phreesia
A number of institutional investors have recently made changes to their positions in PHR. Johnson Financial Group Inc. boosted its holdings in shares of Phreesia by 381.3% in the fourth quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company’s stock worth $28,000 after buying an additional 896 shares during the last quarter. R Squared Ltd purchased a new position in shares of Phreesia in the fourth quarter worth approximately $30,000. BankPlus Trust Department purchased a new position in shares of Phreesia in the fourth quarter worth approximately $34,000. International Assets Investment Management LLC boosted its holdings in shares of Phreesia by 2,179.7% in the third quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock worth $33,000 after buying an additional 1,395 shares during the last quarter. Finally, Quarry LP boosted its holdings in shares of Phreesia by 210.9% in the fourth quarter. Quarry LP now owns 2,835 shares of the company’s stock worth $71,000 after buying an additional 1,923 shares during the last quarter. Hedge funds and other institutional investors own 92.10% of the company’s stock.
About Phreesia
Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.
Read More
- Five stocks we like better than Phreesia
- Short Selling – The Pros and Cons
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- Dividend Capture Strategy: What You Need to Know
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- Canada Bond Market Holiday: How to Invest and Trade
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.